[Form 4] Slide Insurance Holdings, Inc. Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Slide Insurance Holdings, Inc. director and CEO Lucas Bruce reported an open-market sale of common stock by an entity he controls. IIM Holdings II, LLC sold 227,987 shares of Slide Insurance at a weighted average price of $18.95 per share, under a Rule 10b5-1 trading plan adopted on November 21, 2025.
Following the sale, IIM Holdings II, LLC held 34,743,361 shares. Bruce also reported additional indirect holdings through irrevocable trusts and his spouse, along with 1,151,445 shares held directly, indicating a substantial remaining position after these pre-planned transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 227,987 shares ($4,320,354)
Net Sell
6 txns
Insider
Lucas Bruce
Role
Chief Executive Officer
Sold
227,987 shs ($4.32M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 227,987 | $18.95 | $4.32M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 34,743,361 shares (Indirect, By IIM Holdings II, LLC);
Common Stock — 1,151,445 shares (Direct, null)
Footnotes (1)
- Sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2025. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.90 to $19.11 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. The securities reported herein are held by IIM Holdings II, LLC, which is an entity controlled by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. The amount shown reflects the amount owned by the Reporting Person's spouse after the sale of 22,548 shares of common stock on May 27, 2026, pursuant to a 10b5-1 trading plan, at prices ranging from $18.90 to $19.11 per share. Represent shares of common stock beneficially owned by the Reporting Person's spouse through Securus Risk Management LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Represent shares held through the Emma Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Represent shares held through the Ava Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
